No profile data available.
Precigen, Inc. (PGEN) is a healthcare company in the veterinary studies industry, based in Germantown, United States, with about 160 full-time employees.
It reported revenue of $9.68 million for fiscal year 2025, up 146.7% from fiscal year 2024, and net income of -$429.64 million. Its market capitalization was $2.78 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Precigen reported $9.68 million in revenue for fiscal year 2025, up 146.7% from $3.93 million in fiscal year 2024.
$2.78 billion as of October 9, 2026.